Inventor
MARK GELFAND
Inventor
US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Bprimary
A61BDiagnosis38%
A61NElectrotherapy37%
A61MDevices for introducing media into, or onto, the body21%
A61FFilters implantable into blood vessels2%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data2%
PatentTitleYear
12,558,539Detecting and treating disordered breathing202612,440,653Methods and apparatus to increase secretion of endogenous naturetic hormones202512,420,092Systems for treating disordered breathing by comparing stimulated and unstimulated breathing202512,408,978Devices and methods for treating lung tumors202512,369,978Catheter apparatuses, systems, and methods for neuromodulation202512,290,380Method and system to monitor urine output and manage fluid retention in a patient202512,251,150Neuromodulation cryotherapeutic devices and associated systems and methods202512,239,819Method and system to treat acute decompensated heart failure202512,239,839Methods and apparatus to stimulate the heart202512,179,014Transvenous phrenic nerve stimulation system202411,974,804Bilateral renal neuromodulation202411,963,718Microwave catheter apparatuses, systems, and methods for renal neuromodulation202411,963,714Methods and apparatus for renal neuromodulation202411,925,409Devices and methods for treating lung tumors202411,883,659Systems for treating disordered breathing by comparing stimulated and unstimulated breathing202411,864,826Devices and methods for treatment of heart failure by splanchnic nerve ablation202411,844,569Methods and devices for endovascular ablation of a splanchnic nerve202311,801,092Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation202311,759,639Methods and apparatus to stimulate the heart202311,751,939Methods and devices for endovascular ablation of a splanchnic nerve202311,712,296Methods and devices for endovascular ablation of a splanchnic nerve202311,696,985Fluid therapy method202311,577,059Methods and apparatus to increase secretion of endogenous naturetic hormones202311,529,520Methods and apparatus to stimulate heart atria202211,376,066Devices and methods for treatment of heart failure by splanchnic nerve ablation202211,305,114Detecting and treating disordered breathing202211,305,119System and method to modulate phrenic nerve to prevent sleep apnea202211,213,621Fluid therapy method202211,154,354Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to AXON THERAPIES INC (7)· patent assignee history
2021–2026Based in US· patent location history
2022–2026Patents assigned to ZOLL RESPICARDIA INC (6)· patent assignee history
2022–2025Patents assigned to BACKBEAT MEDICAL LLC (5)· patent assignee history
2022–2025Patents assigned to REPRIEVE CARDIOVASCULAR INC (4)· patent assignee history
2024–2025Patents assigned to MEDTRONIC IRELAND MFG UNLIMITED COMPANY (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AXON THERAPIES INC | 7 | 2021–2024 |
| ZOLL RESPICARDIA INC | 6 | 2022–2026 |
| BACKBEAT MEDICAL LLC | 5 | 2022–2025 |
| MEDTRONIC IRELAND MFG UNLIMITED COMPANY | 4 | 2024–2025 |
| REPRIEVE CARDIOVASCULAR INC | 4 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 29 | 2021–2026 |